MedTrace Logo

Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

NCT06953622 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 330

Last updated 2025-05-01

No results posted yet for this study

Summary

To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.

Conditions

Interventions

DRUG

Conservative treatment

Receive no antipaletet drug treatment and surgery

DRUG

Antipaletet drug

Use of antipaletet drugs.

PROCEDURE

Patent Foramen Ovale Closure

Receive the surgery of Patent Foramen Ovale

Sponsors & Collaborators

  • Peking University Third Hospital

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06953622 on ClinicalTrials.gov